MedPath

To rule out the effect of Bramhi Phant and Jatamansi Phant Shirodhara in Anidra (primary insomnia)

Phase 2
Conditions
Health Condition 1: F488- Other specified nonpsychotic mental disorders
Registration Number
CTRI/2023/06/054322
Lead Sponsor
BHUSHAN DEORAOJI MHAISKAR
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

1.Patients of insomnia suffering up to 2 years duration.

2.Patients of either sex with age group 25-65 years.

3.Anidra (insomnia) patients complaining of Angamarda (bodyache), Shirogaurava (heaviness in the head), Shirashoola (headache).

Exclusion Criteria

1.Anidra (insomnia) due to other conditions such as Madatyaya (alcoholism), Abhighata (injury), and other systemic diseases.

2.Patients with secondary insomnia.

3.Psychiatric patients on treatment. Drug induced insomnia.

4.Patients who are already on treatment for insomnia.

5.Patients on hypnotic medicine or other drugs known to cause drowsiness.

6.Pregnant and lactating women.

7.Chronic debilitating diseases.

8.Malignant Hypertension.

9.Pregnant ladies and lactating mothers.

10.Patients contraindicated for Shirodhara karma.

11.Patient not willing for Karma.

12.Individuals whom have had a negative or paradoxical response to an OTC sleep supplement or OTC sleep medication.

13.Individuals with a history of psychiatric illnesses or psychiatric disorders.

14.Individuals who are unaware of specific psychiatric diagnoses but had a history of treatment with antidepressant, neuroleptic medications, or major tranquilizers.

15.Subjects will also be questioned to demonstrate their full understanding of the requirements, demands, and risks of the study and informed of the option to withdraw at any time.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Reliving sign and symptoms of Anidra (primary insomnia in the subjects <br/ ><br>intervenedTimepoint: at baseline, 3 Days and 10 days
Secondary Outcome Measures
NameTimeMethod
Finding best drug intervention which effective on signs and symptoms of Anidra (primary insomnia within 10 daysTimepoint: at baseline, 3 Days and 10 days
© Copyright 2025. All Rights Reserved by MedPath